v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Oct. 27, 2024
Oct. 29, 2023
Cash flows from operating activities    
Net income $ 1,066,213 $ 880,722
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 312,931 276,094
lululemon Studio obsolescence provision 0 23,709
Impairment of assets and restructuring costs 0 74,501
Stock-based compensation expense 71,494 70,157
Settlement of derivatives not designated in a hedging relationship (19,645) 29,499
Changes in operating assets and liabilities:    
Inventories (477,682) (301,801)
Prepaid and receivable income taxes (74,915) (114,616)
Prepaid expenses and other current assets (50,935) 41,202
Other non-current assets (60,638) (30,513)
Accounts payable 45,579 141,685
Accrued liabilities and other 171,566 (16,238)
Accrued compensation and related expenses (133,630) (1,496)
Current and non-current income taxes payable 70,615 (153,539)
Unredeemed gift card liability (66,623) (35,927)
Right-of-use lease assets and current and non-current lease liabilities 16,234 19,898
Other current and non-current liabilities 759 8,729
Net cash provided by operating activities 871,323 912,066
Cash flows from investing activities    
Purchase of property and equipment (454,250) (445,353)
Settlement of net investment hedges 15,041 686
Acquisition, net of cash acquired (130,996) 0
Other investing activities (5,009) (658)
Net cash used in investing activities (575,214) (445,325)
Cash flows from financing activities    
Proceeds from settlement of stock-based compensation 7,277 24,937
Shares withheld related to net share settlement of stock-based compensation (34,259) (30,877)
Repurchase of common stock (1,301,528) (504,643)
Net cash used in financing activities (1,328,510) (510,583)
Effect of foreign currency exchange rate changes on cash and cash equivalents (23,151) (19,887)
Decrease in cash and cash equivalents (1,055,552) (63,729)
Cash and cash equivalents, beginning of period 2,243,971 1,154,867
Cash and cash equivalents, end of period $ 1,188,419 $ 1,091,138